精氨酸酶(ARG)單克隆抗體
Monoclonal Antibody to Arginase (ARG)
ARG1; Arginase I; Liver Arginase
- 編號MAB120Hu23
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 來源單抗制備
- 宿主小鼠
- 效價(克隆號)C7
- Ig亞型 IgG1 Kappa
- 純化方式蛋白A + 蛋白G親和純化
- 標記物無標記物
- 免疫原 RPB120Hu01-精氨酸酶(ARG)重組蛋白
- 緩沖液成份0.01M 磷酸鹽緩沖液（pH7.4，containing 0.05% Proclin-300，50% glycerol）
- 性狀液體
- 濃度1mg/ml
- 且適物種Sus scrofa; Porcine (Pig，豬)
- 應(yīng)用WB; IHC; ICC/IF.
如果抗體需用于流式細胞術(shù)，請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 655 ¥ 1529 ¥ 2184 ¥ 5460 ¥ 21840
- 欲了解實際交易價格和更多情況，請與當?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
DAB staining on IHC-P; Sample: Human Liver Tissue; Primary Ab: 10μg/ml Mouse Anti-Human Arg Antibody Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody (Catalog: SAA544Mu19)
-
DAB staining on IHC-P;
Sample: Human Liver cancer Tissue;
Primary Ab: 10μg/ml Mouse Anti-Human Arg Antibody
Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu19) -
DAB staining on IHC-P;
Sample: Human Liver Tissue
Primary Ab: 10μg/ml Mouse Anti-Human Arg Antibody
Control: Used PBS instead of primary antibody
Second Ab: 2μg/ml HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu19) -
DAB staining on IHC-P;
Sample: Human Liver cancer Tissue
Primary Ab: 10μg/ml Mouse Anti-Human Arg Antibody
Control: Used PBS instead of primary antibody
Second Ab: 2μg/ml HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu19) -
FITC staining on IF;
Samples: Human HepG2 Cells;
Primary Ab: 40μg/ml Mouse Anti-Human Arg Antibody
Second Ab: 1μg/ml FITC-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu18) -
FITC staining on IF;
Sample: HepG2 cell
Primary Ab: 40μg/ml Mouse Anti-Human Arg Antibody
Second Ab: 2μg/ml FITC-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu11)
-
Western Blot Sample: Human Liver lysate Primary Ab: 2μg/ml Mouse Anti-Human Arg Antibody Second Ab: 0.2μg/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody (Catalog: SAA544Mu19)
-
Western Blot; Sample: Lane1: Porcine Liver lysate; Lane2: HepG2 cell lysate
Primary Ab: 0.2μg/ml Mouse Anti-Human Arg Antibody
Second Ab: 0.2μg/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu19)
-
通過ISO 9001、ISO 13485質(zhì)量體系認證
特異性
該抗體是針對ARG的小鼠單克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別ARG。
用法
Western blotting: 0.01-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-40μg/mL;
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當?shù)臈l件下存儲，損失率低于5%。
贈品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPB120Hu01 | 精氨酸酶(ARG)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| APB120Hu01 | 精氨酸酶(ARG)活性蛋白 | Cell?culture;?Activity?Assays. |
| PAB120Hu01 | 精氨酸酶(ARG)多克隆抗體 | WB; IHC; ICC; IP. |
| LAB120Hu71 | 精氨酸酶(ARG)多克隆抗體(生物素標記) | WB; IHC; ICC. |
| LAB120Hu81 | 精氨酸酶(ARG)多克隆抗體(異硫氰酸熒光素標記) | WB; IHC; ICC; IF. |
| MAB120Hu22 | 精氨酸酶(ARG)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB120Hu23 | 精氨酸酶(ARG)單克隆抗體 | WB; IHC; ICC/IF. |
| MAB120Hu24 | 精氨酸酶(ARG)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB120Hu21 | 精氨酸酶(ARG)單克隆抗體 | WB; IHC |
| LAB120Hu72 | 精氨酸酶(ARG)單克隆抗體(生物素標記) | WB; IHC; ICC. |
| SEB120Hu | 精氨酸酶(ARG)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMB120Hu | 精氨酸酶(ARG)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
| KSB120Hu01 | 精氨酸酶(ARG)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻
| 雜志 | 參考文獻 |
| PLoS One | Phenobarbital Induces Alterations in the Proteome of Hepatocytes and Mesenchymal Cells of Rat Livers [Pubmed: 24204595] |
| J Cereb Blood Flow Metab | Arginase I release from activated neutrophils induces peripheral immunosuppression in a murine model of stroke [PubMed: 25966956] |
| Cancer Medicine | Circulating CD14+HLA-DR-/low myeloid-derived suppressor cells in leukemia patients with allogeneic hematopoietic stem cell transplantation: novel clinical potential strategies for the prevention and cellular therapy of graft-versus-host disease [Pubmed:27109254] |
| Cell Mol Immunol? | Toxoplasma gondii GRA15II effector-induced M1 cells ameliorate liver fibrosis in mice infected with Schistosomiasis japonica [Pubmed:27157496] |
| Potent but transient immunosuppression of T-cells is a general feature of erythroid progenitor cells [] | |
| Commun Biol | Potent but transient immunosuppression of T-cells is a general feature of CD71+ erythroid cells [34893694] |
留言咨詢
